ACTRN12614001056684招募中2 期
Pilot study evaluating progression-free survival in patients using a ketogenic diet while receiving chemoradiation for glioblastoma multiforme
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- o limit 至 o limit(—)
- 性别
- All
入选标准
- •* Patients with biopsy-proven glioblastoma multiforme who are considered suitable for standard chemoradiation (including adequate performance status and bone marrow, hepatic and liver function).
- •* Patients must be mentally competent to understand the requirements of the diet and believe that they, with the support of their carers, are capable of achieving them.
- •* Patients have given written informed consent
排除标准
- •* Diabetic patients who are at risk of hypoglycaemic events (such as those on insulin or sulphonylureas)
- •* Current pregnancy or breast-feeding
研究者
相似试验
招募中
2 期
Cisplatin and oral vinorelbine chemotherapy along with radiation for treatment of locally advanced lung cancerStage III Non Small Cell Lung CancerCancer - Lung - Non small cellACTRN12609000003279Royal Adelaide Hospital50
招募中
2 期
Everolimus Treatment in patients with Pancreatic CancerPancreatic Neuroendocrine TumoursCancer - PancreaticACTRN12612001252808Peter MacCallum Cancer Centre20
招募中
不适用
A Phase II Trial to Evaluate the Strategy of Integrating Local Ablative Therapy with First-Line Systemic Treatment for Unresectable Oligometastatic Colorectal Cancer (RESOLUTE)metastatic colorectal cancerCancer - Bowel - Back passage (rectum) or large bowel (colon)Cancer - Bowel - Small bowel (duodenum and ileum)ACTRN12621001198819Cancer Council Victoria50
进行中(未招募)
3 期
Randomised phase III trial comparing concurrent chemoradiation and adjuvant chemotherapy with pelvic radiation alone in high risk and advanced stage endometrial carcinoma: PORTEC-3ACTRN12609000369224The University of Sydney680
撤回
2 期
A Phase II study of midostaurin in combination with standard chemotherapy in newly diagnosed patients with Core Binding Factor Acute Myeloid LeukaemiaACTRN12612000847819Australasian Leukaemia and Lymphoma Group50
